# Plain Language Summary: Make PPE in America Act

This bill is designed to increase the production of personal protective equipment (PPE) like masks, gloves, gowns, and respirators within the United States rather than relying on imports from other countries. The core idea is to build up America's domestic manufacturing capacity so the country isn't dependent on foreign suppliers when emergencies like pandemics or public health crises hit. This became a major concern during the COVID-19 pandemic when the U.S. faced severe shortages of PPE because most of it was manufactured overseas.

The bill likely includes measures to encourage American companies to manufacture PPE domestically, which could involve government support, incentives, or requirements for federal agencies to purchase American-made PPE when possible. It may also address supply chain vulnerabilities by promoting stockpiling of PPE or establishing production facilities that can quickly ramp up during emergencies. The goal is to ensure that when the next health crisis occurs, hospitals, healthcare workers, and the general public won't face the same shortages and delays that happened during COVID-19.

For everyday people, this could mean more jobs in manufacturing sectors, potentially higher prices for PPE in the short term if domestic production costs more than imports, and greater peace of mind knowing the country has a stronger safety net for future emergencies. Taxpayers might see some government spending directed toward supporting these domestic manufacturing efforts, but the bill frames this as an investment in national security and public health preparedness.

Make PPE in America Act

Portman, Rob

Make PPE in America Act This bill requires procurement contracts for personal protective equipment (PPE) to be long-term and for domestically manufactured PPE. Specifically, contracts entered into by the Departments of Homeland Security, Health and Human Services, Defense, Education, or Veterans Affairs for the procurement of PPE must be for a duration of at least three years, including a base period and all option periods, to incentivize investment in the production of PPE, and materials and components of PPE, in the United States. The bill provides exceptions (1) where a nonavailability determination has been made, (2) where a sufficient quantity of a satisfactory quality cannot be procured as and when needed at U.S. market prices, and (3) where the department certifies every 120 days that it is necessary to procure PPE under alternate procedures to respond to the immediate needs of a public health emergency. Such departments may transfer to the Strategic National Stockpile any excess PPE acquired under a contract.